Cargando…

Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension

Inhaled nitric oxide (iNO) is used for acute vasoreactivity testing in pulmonary arterial hypertension (PAH) patients. Inhaled epoprostenol (iPGI(2)) has pulmonary selectivity and is less costly. We sought to compare acute hemodynamic effects of iNO (20 ppm) and iPGI(2) (50 ng/kg/min) and determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Preston, Ioana R., Sagliani, Kristen D., Roberts, Kari E., Shah, Archan M., DeSouza, Shilpa A., Howard, William, Brennan, John, Hill, Nicholas S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641742/ https://www.ncbi.nlm.nih.gov/pubmed/23662176 http://dx.doi.org/10.4103/2045-8932.109916

Ejemplares similares

Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019
por: DeGrado, Jeremy R., et al.
Publicado: (2020)

Successful use of inhaled epoprostenol as rescue therapy for pediatric ARDS
por: Urich, Alissa, et al.
Publicado: (2020)

Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19
por: Sonti, Rajiv, et al.
Publicado: (2020)

HIGH-FLOW NASAL CANULA AND INHALED EPOPROSTENOL RESPONSE IN COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2022)

Inhaled epoprostenol therapy for pulmonary hypertension: Improves oxygenation index more consistently in neonates than in older children
por: Brown, Anna T., et al.
Publicado: (2012)

Refractory Cardiogenic Shock from Right Ventricular Infarction Successfully Managed with Inhaled Epoprostenol
por: Held, Natalie, et al.
Publicado: (2017)

Unexpected Interruptions in the Inhaled Epoprostenol Delivery System: Incidence of Adverse Sequelae and Therapeutic Consequences in Critically Ill Patients
por: Block, Jason M., et al.
Publicado: (2021)

Effects of Inhaled Epoprostenol and Prone Positioning in Intubated Coronavirus Disease 2019 Patients With Refractory Hypoxemia
por: Li, Jie, et al.
Publicado: (2020)

In-vitro and in-vivo comparisons of high versus low concentrations of inhaled epoprostenol to adult intubated patients
por: Li, Jie, et al.
Publicado: (2021)

Improvement of cardiac hemodynamics with inhaled nitric oxide after surgery in patients with mitral stenosis and severe pulmonary hypertension
por: Fernandes, JL, et al.
Publicado: (2005)

Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension
por: Mohammadi, Asma, et al.
Publicado: (2021)

The Use of Inhaled Epoprostenol for Acute Respiratory Distress Syndrome Secondary Due To COVID-19: a Case Series
por: Imtiaz, Komal, et al.
Publicado: (2021)

UTILIZING COMBINATION THERAPY WITH INHALED EPOPROSTENOL AND LOOP DIURETICS IN ACUTE HYPOXIC RESPIRATORY FAILURE FROM COVID-19
por: PINO, MARI-ELENA, et al.
Publicado: (2022)

COMPARISON OF HIGHER VERSUS LOWER DOSE STEROID ADMINISTRATION IN PATIENTS WITH COVID-19 AND ACUTE HYPOXEMIC RESPIRATORY FAILURE ON INHALED EPOPROSTENOL
por: RIEGO, MARIA ATHENA, et al.
Publicado: (2022)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
por: Hill, Nicholas S., et al.
Publicado: (2022)

Inhaled and exhaled nitric oxide
por: Thébaud, B., et al.
Publicado: (1999)

Letter to the Editor: “Use of inhaled epoprostenol with high flow nasal oxygen in non-intubated patients with severe COVID-19”
por: Chiles, Joe W., et al.
Publicado: (2022)

Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19
por: Poonam, Pai B. H., et al.
Publicado: (2022)

Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension
por: Vizza, Carmine D, et al.
Publicado: (2001)

Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
por: Ko, S. Y., et al.
Publicado: (1998)

Inhaled Nitric Oxide before Induction of Anesthesia in Patients with Pulmonary Hypertension
por: Eljezi, Vedat, et al.
Publicado: (2021)

Inhaled nitric oxide: how to deliver it?
por: Troncy, E, et al.
Publicado: (1998)

Epoprostenol sodium for treatment of pulmonary arterial hypertension
por: Saito, Yukihiro, et al.
Publicado: (2015)

Epoprostenol‐associated ascites in pulmonary arterial hypertension
por: Schoenberg, Noah C., et al.
Publicado: (2022)

A Comparison of Inhaled Epoprostenol in Patients With Acute Respiratory Distress Syndrome and COVID-19-Associated Acute Respiratory Distress Syndrome
por: Robinson, John, et al.
Publicado: (2022)

Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
por: Loureiro, Maria José, et al.
Publicado: (2007)

Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension
por: Wang, Lan, et al.
Publicado: (2017)

An electrochemical nitric oxide generator for in-home inhalation therapy in pulmonary artery hypertension
por: Liu, Yiwei, et al.
Publicado: (2022)

Inhaled nitric oxide in postpneumonectomy pulmonary edema
por: Keegan, MT, et al.
Publicado: (2003)

Inhaled nitric oxide in infants and children with ARDS
por: Zobel, G, et al.
Publicado: (2000)

Inhaled nitric oxide applications in paediatric practice
por: Bernasconi, A, et al.
Publicado: (2002)

The role of inhaled nitric oxide beyond ARDS
por: Khan, Muhammad Faisal, et al.
Publicado: (2014)

Inhaled nitric oxide, methemoglobinemia, and route of delivery
por: Raut, Monish S., et al.
Publicado: (2017)

Successful Weaning From Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) After Initiation of Inhaled Epoprostenol in a Neonate With Refractory Persistent Pulmonary Hypertension of the Newborn (PPHN)
por: Shehzad, Irfan, et al.
Publicado: (2023)

A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension
por: Stene Hurtsén, Anna, et al.
Publicado: (2020)

Inhaled Nitric Oxide Counterbalances ET-1 Dependent Pulmonary Hypertension and Bronchoconstriction in the Pig
por: Clement, M. G., et al.
Publicado: (1994)

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn refractory to high-frequency ventilation
por: Al-Alaiyan, Saleh, et al.
Publicado: (1999)

Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
por: Hajian, Bita, et al.
Publicado: (2016)

Epoprostenol: Flushing or Erythroderma?
por: Martínez-Martínez, María Luisa, et al.
Publicado: (2013)

Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
por: Timofeev, Julia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vg0kej3srk5aipmsbmbv3ah7vk